3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gynecologic
3
Breast
3
Conditions
Breast Neoplasms
51
Neoplasms
34
Colorectal Neoplasms
23
Lung Neoplasms
17
Prostatic Neoplasms
16
Melanoma
15
Neoplastic Cells, Circulating
13
Pancreatic Neoplasms
11
Multiple Myeloma
11
Uterine Cervical Neoplasms
10
Ovarian Neoplasms
10
Carcinoma, Non-Small-Cell Lung
8
Papillomavirus Infections
7
Neoplasm Metastasis
7
Leukemia, Myeloid, Acute
7
Colonic Neoplasms
7
Lymphoma, Follicular
6
Lymphoma
6
Hematologic Neoplasms
6
Uveal Melanoma
5
Sarcoma
5
Head and Neck Neoplasms
5
Glioma
5
Uterine Cervical Dysplasia
4
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Glioblastoma
4
Disease
4
COVID-19
4
Interventions
Blood Specimen Collection
3
veliparib
2
Surveys and Questionnaires
2
Counseling
2
Carboplatin
2
Zoledronic Acid
1
Videotape Recording
1
Telemedicine
1
Taxes
1
Tamoxifen
1
Standard of Care
1
Specimen Handling
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Palliative Care
1
Paclitaxel
1
Letrozole
1
Genotype
1
Genetic Counseling
1
Exercise Test
1
Echocardiography
1
Early Intervention, Educational
1
Docetaxel
1
Diet, Mediterranean
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
Hereditary Breast and Ovarian Cancer Syndrome
×
Blood Specimen Collection
×
Clear all
NCT02324062
2026-02-18
HCP
University of Southern California
Completed
1,511 enrolled
NCT03510689
2024-10-16
Gene-HEART
Abramson Cancer Center at Penn Medicine
Completed
79 enrolled
NCT01333748
2012-07-13
EXSAL
Centre Francois Baclesse
Phase 2
Completed
530 enrolled